| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
Strong Demand Drives Net Sales and Gross Profit Growth in Both Segments |
| 30 Oct 2026 | SCHEDULE 13G |
| 26 Oct 2026 | ARS |
| 26 Oct 2026 | DEFA14A |
| 26 Oct 2026 |
Proxy statement: annual meeting on December 8, 2026
CEO pay $9.7M, up 18% · say-on-pay vote |
| 20 Oct 2026 | SCHEDULE 13G/A |
| 09 Oct 2026 | SCHEDULE 13G/A |
| 15 Sep 2026 | 144/A |
| 15 Sep 2026 | 144/A |
| 14 Sep 2026 |
Form 4: Mathis Charles Alexander, Director
Sold 3,000 shares ($174K) |
| 14 Sep 2026 |
Form 4: Baur Michael L, Director
Received 19,980 shares by exercise or conversion ($739K) · Sold 19,980 shares ($1.11M) · Received 57,359 shares by exercise or conversion ($2.12M) · 1 more |
| 11 Sep 2026 | 144 |
| 11 Sep 2026 | 144 |
| 10 Sep 2026 | 144 |
| 04 Sep 2026 |
Form 4: Ford Brandy, SVP & Chief Accounting Officer
Sold 5,293 shares ($304K) |
| 04 Sep 2026 | 144 |
| 03 Sep 2026 |
Form 4: Mathis Charles Alexander, Director
Received 3,234 shares as a grant or award |
| 03 Sep 2026 |
Form 4: Emory Frank Edward Jr., Director
Received 3,234 shares as a grant or award |
Loading...